CPWM LLC’s AstraZeneca AZN Stock Holding History

CPWM LLC’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$1.06M	Sell	9,625 -428	-4%	-$54.3K	0.1%	124
2022 Q2	$1.33M	Buy	10,053 +379	+4%	+$49.7K	0.12%	128
2022 Q1	$1.28M	Buy	9,674 +58	+0.6%	+$6.96K	0.09%	121
2021 Q4	$1.16M	Hold	9,616	–	–	0.09%	135
2021 Q3	$1.16M	Buy	9,616 +25	+0.3%	+$2.91K	0.11%	108
2021 Q2	$1.15M	Buy	9,591 +113	+1%	+$12.4K	0.09%	111
2021 Q1	$942K	Buy	9,478 +32	+0.3%	+$3.22K	0.08%	151
2020 Q4	$944K	Sell	9,446 -34	-0.4%	-$3.6K	0.09%	143
2020 Q3	$1.04M	Buy	9,480 +10	+0.1%	+$1.11K	0.11%	117
2020 Q2	$1M	Buy	9,470 +165	+2%	+$17K	0.11%	116
2020 Q1	$831K	Hold	9,305	–	–	0.12%	113
2019 Q4	$928K	Hold	9,305	–	–	0.11%	130
2019 Q3	$829K	Hold	9,305	–	–	0.11%	137
2019 Q2	$768K	Hold	9,305	–	–	0.11%	143
2019 Q1	$752K	Hold	9,305	–	–	0.11%	144
2018 Q4	$707K	Sell	9,305 -6	-0.1%	-$469	0.12%	127
2018 Q3	$737K	Buy	9,311 +27	+0.3%	+$2.04K	0.1%	139
2018 Q2	$652K	Hold	9,284	–	–	0.1%	148
2018 Q1	$649K	Buy	+9,284	New	+$643K	0.1%	153

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

CPWM LLC's AZN Position: Q3 2022 in Review

CPWM LLC reduced its AstraZeneca (AZN) stake by 4.3% in Q3 2022, selling an estimated $54.3K and leaving 9,625 shares worth $1.06M. The position accounts for 0.1% of the portfolio, ranked #124.

CPWM LLC first reported a position in AZN in Q1 2018 and has held it in 19 quarters since. The position peaked at $1.33M in Q2 2022. 965 funds tracked by Wall St. Rank hold AZN as of Q3 2022.

CPWM LLC held 9,625 shares of AstraZeneca worth $1.06M as of Q3 2022.
CPWM LLC sold 428 AstraZeneca shares in Q3 2022, an estimated $54.3K.
AstraZeneca made up 0.1% of CPWM LLC's portfolio in Q3 2022, its #124 holding.
CPWM LLC first reported a position in AstraZeneca in Q1 2018 and has held it in 19 quarters since.
CPWM LLC's AstraZeneca position peaked at $1.33M in Q2 2022.
965 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2022.

Based on CPWM LLC's 13F filing for Q3 2022, filed 14 Nov 2022.